Role of Renal Sympathetic Nerves in GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Exendin-4-Mediated Diuresis and Natriuresis in Diet-Induced Obese Rats

被引:9
|
作者
Liu, Xuefei [1 ]
Patel, Kaushik P. [2 ]
Zheng, Hong [1 ]
机构
[1] Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA
[2] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA
来源
基金
美国国家卫生研究院;
关键词
glucagon-like peptide-1; neprilysin; obesity; renal nerve; sodium retention; BLOOD-PRESSURE; HEART-FAILURE; SODIUM-EXCRETION; HYPERTENSION; NEPRILYSIN; LIRAGLUTIDE; EXPRESSION; IMPACT; INJURY;
D O I
10.1161/JAHA.121.022542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The gut-derived hormone GLP-1 (glucagon-like peptide-1) exerts beneficial effects against established risk factors for chronic kidney disease. GLP-1 influences renal function by stimulating diuresis and natriuresis and thus lowering arterial blood pressure. The role of the sympathetic nervous system has been implicated as an important link between obesity with elevated arterial pressure and chronic kidney disease. The primary aim of this study was to determine the contribution of renal sympathetic nerves on intrapelvic GLP-1-mediated diuresis and natriuresis in high-fat diet (HFD)-induced obese rats. Methods and Results Obesity was induced in rats by HFD for 12 weeks, followed by either surgical bilateral renal denervation or chronic subcutaneous endopeptidase neprilysin inhibition by sacubitril for a week. Diuretic and natriuretic responses to intrapelvic administration of the GLP-1R (GLP-1 receptor) agonist exendin-4 were monitored in anesthetized control and HFD rats. Renal GLP-1R expression and neprilysin expression and activity were measured. The effects of norepinephrine on the expression of GLP-1R and neprilysin in kidney epithelial LLC-PK1 cells were also examined. We found that diuretic and natriuretic responses to exendin-4 were significantly reduced in the HFD obese rats compared with the control rats (cumulative urine flow at 40 minutes, 387 +/- 32 versus 650 +/- 65 mu L/gkw; cumulative sodium excretion at 40 minutes, 42 +/- 5 versus 75 +/- 10 mu Eq/gkw, P<0.05). These responses in the HFD rats were restored after ablation of renal nerves (cumulative urine flow at 40 minutes, 625 +/- 62 versus 387 +/- 32 mu L/gkw; cumulative sodium excretion at 40 minutes, 70 +/- 9 versus 42 +/- 5 mu Eq/gkw, P<0.05). Renal denervation induced significant reductions in arterial pressure and heart rate responses to intrapelvic GLP-1 in the HFD rats. Renal denervation also significantly increased the GLP-1R expression and reduced neprilysin expression and activity in renal tissues from the HFD rats. Chronic subcutaneous neprilysin inhibition by sacubitril increased GLP-1-induced diuretic and natriuretic effects in the HFD rats. Finally, exposure of the renal epithelial cells to norepinephrine in vitro led to downregulation of GLP-1R expression but upregulation of neprilysin expression and activity. Conclusions These results suggest that renal sympathetic nerve activation contributes to the blunted diuretic and natriuretic effects of GLP-1 in HFD obese rats. This study provides significant novel insight into the potential renal nerve-neprilysin-GLP-1 pathway involved in renal dysfunction during obesity that leads to hypertension.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice
    Brown, Jacob D.
    McAnally, Danielle
    Ayala, Jennifer E.
    Burmeister, Melissa A.
    Morfa, Camilo
    Smith, Layton
    Ayala, Julio E.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2018, 315 (04) : R595 - R608
  • [2] Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, modulates the effect of macronutrients on food intake in rats
    Aziz, A
    Anderson, GH
    FASEB JOURNAL, 2002, 16 (04): : A24 - A25
  • [3] IMPROVED HEPATIC STEATOSIS IN OBESE MICE AND RATS AFTER SUSTAINED TREATMENT WITH THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONIST, EXENDIN-4
    Trevaskis, James
    Griffin, Peter
    Wittmer, Carrie
    Aumann, Don
    Tatarkiewicz, Krystyna
    Kesty, Nicole C.
    Parkes, David
    Roth, Jonathan D.
    Chen, Steve
    HEPATOLOGY, 2009, 50 (04) : 1169A - 1169A
  • [4] Glucagon like peptide-1 (GLP-1) induces diuresis and natriuresis in rats by both renal hemodynamic and tubular mechanisms
    Muniz Pacheco, Bruna Piccolo
    Crajoinas, Renato de Oliveira
    Oricchio, Felipe Theocharides
    Abreu Lessa, Lucilia Maria
    Malnic, Gerhard
    Costa Girardi, Adriana Castello
    FASEB JOURNAL, 2011, 25
  • [5] Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature
    Savignano, Fernanda A.
    Crajoinas, Renato O.
    Pacheco, Bruna P. M.
    Campos, Luciene C. G.
    Shimizu, Maria Heloisa M.
    Seguro, Antonio Carlos
    Girardi, Adriana C. C.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 811 : 38 - 47
  • [6] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [7] Glucagon-like peptide-1 mediated renal sympathetic activation in obese rats: role of intrarenal mechanisms
    Zheng, Hong
    Liu, Xuefei
    FASEB JOURNAL, 2020, 34
  • [8] Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
    Ja'arah, Daria
    Al Zoubi, Mazhar Salim
    Abdelhady, Gamal
    Rabi, Firas
    Tambuwala, Murtaza M.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2021, 14
  • [9] Role of the renal nerves in regulating GLP-1 mediated diuresis and natriuresis in rats with heart failure
    Katsurada, Kenichi
    Sharma, Neeru M.
    Zheng, Hong
    Liu, Xuefei
    Nandi, Shyam S.
    Patel, Kaushik P.
    FASEB JOURNAL, 2019, 33
  • [10] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676